Trials / Unknown
UnknownNCT00689494
Cervical Device Contraception-2 (Nanopaz)
Cervical Device Contraception
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Bnai Zion Medical Center · Other Government
- Sex
- Female
- Age
- 1 Month – 2 Months
- Healthy volunteers
- Accepted
Summary
Measure blood progesterone by using cervical device contraception.
Detailed description
A very small cervical device that releases small amount of progesterone 20 mcgm/day. The target of the research is to measure blood progesterone by using the cervical device. This small device delivers progesterone by nanotechnology method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Nanopaz contraception device | levonorgestrel and levonorgestrel device for cervical contraception-nantechnolgy method |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-12-01
- Completion
- 2010-05-01
- First posted
- 2008-06-03
- Last updated
- 2008-06-03
Source: ClinicalTrials.gov record NCT00689494. Inclusion in this directory is not an endorsement.